Submitted by Anonymous (not verified) on 16 July 2026 - 15:55
Human medicines European public assessment report (EPAR): Bimervax, COVID-19 Vaccine (recombinant, adjuvanted), Date of authorisation: 30/03/2023, Revision: 15, Status: Authorised
Source: